ELV
Elevance Health Inc
NEW YORK STOCK EXCHANGE, INC.· Health Care· US· IPO 2001-10-30
$413.75
+0.15 (+0.04%)
last quote
Want the full multi-source brief on ELV?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$413.75
High
$417.38
Low
$411.47
Previous close
$413.60
Fundamentals
Market cap
$89.36B
P/E (TTM)
17.39x
P/S (TTM)
0.44x
P/B
1.78x
Gross margin
—
Operating margin
3.81%
Net margin
2.55%
Rev growth (YoY)
3.60%
EPS growth (YoY)
-4.07%
ROE
11.59%
52W high
$450.69
52W low
$274.84
Beta
0.60x
Industry peers
by market cap
Upcoming earnings
next 30 days
2027-01-26in 82 daysafter market
Q4 2026EPS est $2.08Rev est $49739.3M
Recent SEC filings
CIK 1156039filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 1d
Elizabeth Warren Wants to Break Up UnitedHealth, and One Day Later a Nonprofit Called It Undervalued
Elizabeth Warren is pushing to dismantle UnitedHealth Group just as a nonprofit investor education group moves in the opposite direction, naming the embattled insurer its top undervalued pick for early 2027. The timing raises a question every UNH shareholder needs to answer.
Yahoo · 1d
Will UNH's Optum Insight Spending Translate Into Profit Growth?
UnitedHealth is scaling AI solutions across Optum Insight to boost efficiency, improve claims processing and drive long-term growth despite rising costs.
Yahoo · 2d
Is CVS Health Stock Worth More Than Its Competitors?
For questions about this article or underlying research, email help@trefis.com.
Yahoo · 4d
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should Know
Does Elevance Health (ELV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Yahoo · 5d
THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
Tenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.
Yahoo · 6d
AxoGen, Inc. Q3 2026 Earnings Call Summary
Moby summary of AxoGen, Inc.'s Q3 2026 earnings call
Benzinga · 6d
Elevance Health Files Prospectus For Mixed Shelf Offering; Terms Not Disclosed
https://www.sec.gov/Archives/edgar/data/1156039/000119312526436231/d165308ds3asr.htm
Yahoo · 6d
BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
Boston Scientific's third-quarter revenues beat estimates, but contracting margins, weaker segment sales and reduced 2026 guidance weigh on shares.
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial